Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4070539
Max Phase: Preclinical
Molecular Formula: C25H35ClN3NaO8S
Molecular Weight: 574.10
Molecule Type: Small molecule
Associated Items:
ID: ALA4070539
Max Phase: Preclinical
Molecular Formula: C25H35ClN3NaO8S
Molecular Weight: 574.10
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1CC[C@@H](C(O)S(=O)(=O)[O-])NC(=O)C2(CCCCC2)NC(=O)OC(c2cccc(Cl)c2)CCCCCN1.[Na+]
Standard InChI: InChI=1S/C25H36ClN3O8S.Na/c26-18-9-7-8-17(16-18)20-10-3-1-6-15-27-21(30)12-11-19(22(31)38(34,35)36)28-23(32)25(29-24(33)37-20)13-4-2-5-14-25;/h7-9,16,19-20,22,31H,1-6,10-15H2,(H,27,30)(H,28,32)(H,29,33)(H,34,35,36);/q;+1/p-1/t19-,20?,22?;/m0./s1
Standard InChI Key: YAXBNRVGUCOAPN-VHUMMCJUSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 574.10 | Molecular Weight (Monoisotopic): 573.1912 | AlogP: 2.97 | #Rotatable Bonds: 3 |
Polar Surface Area: 171.13 | Molecular Species: ACID | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -0.80 | CX Basic pKa: | CX LogP: 1.53 | CX LogD: 0.25 |
Aromatic Rings: 1 | Heavy Atoms: 38 | QED Weighted: 0.34 | Np Likeness Score: 0.19 |
1. Damalanka VC, Kim Y, Galasiti Kankanamalage AC, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.. (2017) Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease., 127 [PMID:28038326] [10.1016/j.ejmech.2016.12.033] |
Source(1):